No Data
No Data
Guolian Securities: Increased attention to tumor immunology, recommend focusing on targeted drugs such as PD1/IL2 in pharmaceutical companies.
With the increasing attention to tumor immunity, and the successive launch of advantageous products, bullish on PD1/IL2 and PD1/IL15 targeted drugs.
These Stocks Held Up During the Selloff. What That Reveals About the Market.
Labcorp Holdings Insider Sold Shares Worth $2,770,552, According to a Recent SEC Filing
Labcorp Holdings Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
Insider Sale: EVP, CIO & CTO Lance Berberian Sells 12,093 Shares of Labcorp Holdings Inc (LH)
Insiders Who Sold US$6.9m Of Labcorp Holdings Made The Right Call
No Data
webguybob : The Etsy downgrade surprised me!
105535782 : ok
102242135 Lim : K